AU2798900A - Utilisation of thiadizole derivatives for the prophylactic and therapeutic treatment of infections - Google Patents

Utilisation of thiadizole derivatives for the prophylactic and therapeutic treatment of infections

Info

Publication number
AU2798900A
AU2798900A AU27989/00A AU2798900A AU2798900A AU 2798900 A AU2798900 A AU 2798900A AU 27989/00 A AU27989/00 A AU 27989/00A AU 2798900 A AU2798900 A AU 2798900A AU 2798900 A AU2798900 A AU 2798900A
Authority
AU
Australia
Prior art keywords
thiadizole
utilisation
prophylactic
infections
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27989/00A
Inventor
Hassan Jomaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2798900A publication Critical patent/AU2798900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU27989/00A 1999-01-29 2000-01-27 Utilisation of thiadizole derivatives for the prophylactic and therapeutic treatment of infections Abandoned AU2798900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19903398 1999-01-29
DE19903398A DE19903398A1 (en) 1999-01-29 1999-01-29 Use of thiadiazole derivatives for the prophylactic and therapeutic treatment of infections
PCT/EP2000/000613 WO2000044359A2 (en) 1999-01-29 2000-01-27 Utilisation of thiadizole derivatives for the prophylactic and therapeutic treatment of infections

Publications (1)

Publication Number Publication Date
AU2798900A true AU2798900A (en) 2000-08-18

Family

ID=7895681

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27989/00A Abandoned AU2798900A (en) 1999-01-29 2000-01-27 Utilisation of thiadizole derivatives for the prophylactic and therapeutic treatment of infections

Country Status (3)

Country Link
AU (1) AU2798900A (en)
DE (1) DE19903398A1 (en)
WO (1) WO2000044359A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112294795A (en) * 2020-11-17 2021-02-02 北京化工大学 Application of artemether in treating and preventing coxsackie virus infection

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329924B2 (en) 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
PT1401825E (en) * 2001-06-11 2009-10-23 Virochem Pharma Inc Thiophene derivatives as antiviral agents for flavivirus infection
US7402608B2 (en) 2002-12-10 2008-07-22 Virochem Pharma Inc. Compounds and methods for the treatment or prevention of Flavivirus infections
CA2607359C (en) 2005-05-13 2011-08-09 Virochem Pharma Inc. Compounds and methods for the treatment or prevention of flavivirus infections
BRPI0718915A2 (en) 2006-11-15 2013-12-03 Virochem Pharma Inc THIOPHEN ANALOGS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
ES2824261T3 (en) 2007-09-14 2021-05-11 Biogen Ma Inc Compositions and procedures for the treatment of progressive multifocal leukoencephalopathy (PML)
CN102626415B (en) * 2012-03-21 2014-08-06 山东省千佛山医院 Application of combination of tetracycline medicine and fluconazole in preparation of antifungal product, and product thereof
AU2014348451A1 (en) * 2013-11-14 2016-06-16 Avista Pharma Solutions, Inc. Antiparasitic compounds
CA2960331A1 (en) 2014-09-12 2016-03-17 Antibiotx Aps Antibacterial use of halogenated salicylanilides
CN104606215B (en) * 2014-12-31 2017-10-10 中国医学科学院病原生物学研究所 A kind of medicine for suppressing Enterovirus 71
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
CN115109053A (en) * 2022-06-08 2022-09-27 深圳湾实验室 Thiazolesulfinyl thiadiazole derivative, intermediate, preparation method and application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07233157A (en) * 1994-02-18 1995-09-05 Sagami Chem Res Center 1,2,3-thiadiazole derivative
JPH07233069A (en) * 1994-02-18 1995-09-05 Sagami Chem Res Center 5-lipoxygenase inhibitor comprising 1,2,3-thiadiazole derivative as active ingredient

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112294795A (en) * 2020-11-17 2021-02-02 北京化工大学 Application of artemether in treating and preventing coxsackie virus infection
CN112294795B (en) * 2020-11-17 2022-03-29 北京化工大学 Application of artemether in treating and preventing coxsackie virus infection

Also Published As

Publication number Publication date
WO2000044359A3 (en) 2000-09-28
DE19903398A1 (en) 2000-08-10
WO2000044359A2 (en) 2000-08-03

Similar Documents

Publication Publication Date Title
HK1047243A1 (en) A means for the prophylactic and therapeutic treatment of streptococcal infections
AU3885600A (en) Splint bandage and method
AU7907300A (en) Novel combination of loteprednol and antihistamines
AU2001269314A1 (en) Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
AU715620C (en) Therapeutic methods and uses
AU2798900A (en) Utilisation of thiadizole derivatives for the prophylactic and therapeutic treatment of infections
AU4364400A (en) Azaindole derivatives for the treatment of depression
AU4774597A (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
AU2001279958A1 (en) Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatorydisorders
AU2281601A (en) Treatment of viral infections using levovirinTM
HUP0105310A2 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
AU5842300A (en) Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
AU1962801A (en) Device for treatment of spider veins
IL146465A0 (en) Substituted 3-pyridyl-4-arylpyrroles and related therapeutic and prophylactic methods
AU3760900A (en) Treatment of menstrual function
AU2000275035A1 (en) Therapeutic and prophylactic drugs of myopia
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
AU4145999A (en) Topical drug for the treatment of viral infections
AU2566201A (en) Compounds and methods for the treatment of pain
AU1618901A (en) Treatment of rosacea
AU1405001A (en) Treatment of diseases
AU1392601A (en) Prevention and treatment of biomaterial-associated infections
AU4475300A (en) Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression
AU3524700A (en) Prevention and treatment of viral infections
IL143795A0 (en) Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase